Arely Vergara-Castañeda

Dr. Arely Vergara-Castañeda

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Alonso Vivar-SierraAlonso Vivar-Sierra
Alonso Vivar-Sierra
MAMaría José Araiza-Macías
María José Araiza-Macías
JHJosé Patricio Hernández-Contreras
José Patricio Hernández-Contreras
AVArely Vergara-Castañeda
Arely Vergara-Castañeda
GRGabriela Ramírez-Vélez
Gabriela Ramírez-Vélez
MLMarco A. Loza-Mejía
Marco A. Loza-Mejía
SARS-CoV-2 infects host cells by interacting its spike protein with surface angiotensin-converting enzyme 2 (ACE2) receptors, expressed in lung and other cell types. Although several risk factors could explain why some countries have lower incidence and fatality rates than others, environmental factors such as diet should be considered. It has been described that countries with high polyunsaturated fatty acid (PUFA) intake have a lower number of COVID-19 victims and a higher rate of recovery from the disease. Moreover, it was found that linoleic acid, an omega-6 PUFA, could stabilize the spike protein in a closed conformation, blocking its interaction with ACE2. These facts prompted us to perform in silico simulations to determine if other PUFA could also stabilize the closed conformation of spike protein and potentially lead to a reduction in SARS-CoV-2 infection. We found that: (a) countries whose source of omega-3 is from marine origin have lower fatality rates; and (b) like linoleic acid, omega-3 PUFA could also bind to the closed conformation of spike protein and therefore, could help reduce COVID-19 complications by reducing viral entrance to cells, in addition to their known anti-inflammatory effects.

ABAdriana Benitez-Rico
Adriana Benitez-Rico
APArizbeth Pérez
Arizbeth Pérez
BMBryan Isaac Muñóz-López
Bryan Isaac Muñóz-López
LAURA MARTINO-ROAROLAURA MARTINO-ROARO
LAURA MARTINO-ROARO
Jorge Adan Alegría BañosJorge Adan Alegría Baños
Jorge Adan Alegría Baños
AIAlejandro Islas-García
Alejandro Islas-García
Nowadays, the contamination caused by emerging pollutants is a global concern due to the lack of scientific evidence to demonstrate the risk or toxicity to humans due to the presence of pharmaceutical residues in the environment. This study aimed to identify and describe the disposal practices of unused and unwanted medications, as well as to analyze and identify the most frequent drugs determined on water bodies adjacent to the biggest urban population in Mexico. A two-phase study with an epidemiological and an ecological assessment was performed. The epidemiological phase was carried out with a descriptive cross-sectional study among citizens from Mexico City and the metropolitan area using an electronic survey applied to 719 subjects aimed to assess practices in which pharmaceutical products are disposed. The ecological phase included a review of scientific reports. The results show that nearly 83.5% of those surveyed use inappropriate practices for disposal medicines, the main ones are through the municipal dump or directly in the drain. The ecological approach was carried out by a systematic literature review of original reports published between 2013 to 2023; information about the class of drugs, active substance, environmental compartments, location, and concentration was extracted and presented. Fifty-one different types of pharmaceutical residues were detected in wastewater in Mexico City in the last decade. The results of this study can contribute to the application of public policies for waste management authorities to mitigate the socio-environmental risks due to the inappropriate disposal of medicines.

9 April 2021 in Nova Scientia
Verified
Journal Article
Open access
PDF file
TCTomás Eduardo Chávez-Miyauchi
Tomás Eduardo Chávez-Miyauchi
ABAdriana Benitez-Rico
Adriana Benitez-Rico
MAManuel Alcántara-Flores
Manuel Alcántara-Flores
AVArely Vergara-Castañeda
Arely Vergara-Castañeda
AOAna Belén Ogando-Justo
Ana Belén Ogando-Justo
COVID-19 pandemic has changed the normal course of activities around the World. The measures implemented to slow down the spread of the disease and its impact on the health system have also suggested a change in population dynamics. In the educational aspect, the paradigm of the traditional education had to change completely to a remote environment, representing a challenge for students, teachers, and education institutions. In this work we report the students’ response to the actions taken by the faculty of the Chemistry Sciences School of Universidad La Salle México to face online courses ensuring student accompaniment. After the term, a qualitative and quantitative study was performed to the school population using an electronic survey to address the response of students to the applied strategy. Data was analyzed using SPSS® software. 266 responses were obtained, which represents a response rate of 44%. 75.6% of the alumni reported having a good or excellent disposition regarding virtual sessions. Likewise, 48.9% reported adapting appropriately to the remote working modality. Also, 83.5% of students recognize the labor of the teachers by acknowledging that their effort and dedication was excellent or good. Students showed development of soft skills such as self-time and learning management; written, oral and technological communication. These results suggest the advantages perceived by students during the transition to virtual modality, mostly oriented to self-management of their learning and that could conform the basis for the development of new strategies that can be useful not only for a contingency situation, but also in the structuration and innovation of science programs.

17 January 2024 in Diseases
Verified
Journal Article
Open access
PDF file
DRDiana Rodríguez-Vera
Diana Rodríguez-Vera
Juan Rodrigo SalazarJuan Rodrigo Salazar
Juan Rodrigo Salazar
Marvin A. Soriano-UrsuaMarvin A. Soriano-Ursua
Marvin A. Soriano-Ursua
JGJessica Guzmán-Pérez
Jessica Guzmán-Pérez
AVArely Vergara-Castañeda
Arely Vergara-Castañeda
Rodolfo Pinto-AlmazánRodolfo Pinto-Almazán
Rodolfo Pinto-Almazán
Background and Objectives: The development of severe COVID-19 is related to the preexistence of comorbidities and an inadequate nutritional status. The latter is a critical factor for the development of infection and the progression of the disease. Notably, optimal nutrition impacts immune system function, as malnutrition is related to high cytokine levels in the late phase of the disease, correlating with a poor prognosis. In this sense, omega-3 fatty acids (O3FAs) have anti-inflammatory properties that may reduce morbidity and mortality from COVID-19 infection. O3FAs are linked to a better prognosis in COVID-19 patients. Materials and Methods: In this randomized, double-blind clinical trial, we evaluate the administration of O3FAs to unvaccinated Mexican patients for two weeks starting after the first two hours of hospitalization. Results: The findings support the notion that O3FAs (in a dose high enough to satisfy human physiological requirements in a short time, one capsule of 1.4 g O3FAs daily) exert a comprehensive multi-systemic modulatory influence, affecting inflammatory and metabolic pathways. Significant perturbations in biomarkers, including absolute neutrophil count, hematocrit, and platelet indices, underscore the compound’s anti-inflammatory effect. Concurrently, the intervention modulates pivotal metabolic and hepatic parameters, attenuating cardiovascular risk profiles and expediting patient convalescence. These multifarious effects are likely orchestrated through intricate biochemical mechanisms and are subject to individual variations predicated on metabolic factors. Conclusions: The results of this trial support the notion that O3FA supplementation has beneficial effects on COVID-19 patients with moderate presentation by regulating metabolism and limiting inflammation.

20 November 2020 in Revista del Centro de Investigación de la Universidad la Salle
Verified
Journal Article
Open access
PDF file
María del Rosario Ayala-MorenoMaría del Rosario Ayala-Moreno
María del Rosario Ayala-Moreno
EREnriqueta Mancilla Rendón
Enriqueta Mancilla Rendón
Carmen LozanoCarmen Lozano
Carmen Lozano
AVArely Vergara-Castañeda
Arely Vergara-Castañeda
Introducción. Los costos del tratamiento de la diabetes mellitus (DM), representan un problema en México, un país con desigualdad social y sistemas de salud precarios. Este ensayo describe los gastos en la prevención y control de la DM y su impacto socio-económico basados en el derecho a la salud. Se analiza la proyección al 2022 de costos directos e indirectos, basados en un análisis de series de tiempo de las partidas del Gasto Social de la Administración Pública Federal. Discusión. Se estima gran variabilidad y futuro incierto del gasto asignado a prevención y control de la DM al 2022; además, el gasto para tratamiento farmacológico tiende a desaparecer en tres años. Conclusiones. México muestra un panorama desalentador en el gasto para la atención de la DM. Urge analizar y reorientar la distribución del gasto que asegure la prevención y el tratamiento del paciente, centrándose en el derecho a la salud.

Verified
Journal Article
Open access
PDF file
DRDiana Rodríguez-Vera
Diana Rodríguez-Vera
MGManuel Abraham Gomez-Martínez
Manuel Abraham Gomez-Martínez
MHMildred Valeria Herrera-Picazo
Mildred Valeria Herrera-Picazo
LRLiliana Anguiano Robledo
Liliana Anguiano Robledo
CTCecilia Tufiño
Cecilia Tufiño
JMJose A. Morales-González
Jose A. Morales-González
Obesity is a complex metabolic disorder resulting from interactions among genetic, environmental, and dietary factors. Traditional clinical markers may provide limited insight into the biochemical mechanisms that link nutrition and metabolic dysfunction; in this context, the epigenetic mechanisms through which nutrients modulate gene expression are central to understanding metabolic homeostasis. This review summarizes the published evidence on nutrient-driven epigenetic processes in obesity, focusing on DNA methyl donors, such as folate, vitamin B12, choline, betaine, serine, and methionine, and their effects on methylation and DNA methyltransferase activity. Metabolites such as acetyl-CoA, NAD+, and short-chain fatty acids (SCFAs) can also influence histone modifications, while diet-responsive microRNAs can regulate networks involved in adipogenesis, lipid metabolism, inflammation, and insulin signaling. Recent studies have identified epigenetic signatures associated with adiposity and metabolic traits, many of which are linked to the risk of cardiometabolic disease. This review is structured around the concept that nutrient-sensitive epigenetic mechanisms act as candidate biomarkers, linking dietary exposure to metabolic dysfunction. Recent evidence supports the idea that nutrient–epigenetic variation could complement traditional metabolic evaluations by offering mechanistic insight and translational direction. These findings suggest that nutrient-sensitive epigenetic mechanisms are biologically plausible candidate biomarker layers; however, their clinical implementation is currently limited by issues including tissue specificity, reproducibility, and the need for prospective validation.